Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

This looked at patients with transplant-eligible newly diagnosed multiple myeloma, and randomly assigned the patients ... At ...

News of the re-examination has also been applauded by patient organisation Myeloma UK, which has been supporting Sanofi ...

Hand-in-hand with overall survival, CARVYKTI has also maintained significant improvement in progression-free survival as ...

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

Q3 2024 revenue was $6.1 million, which comprises $6.6 million in core product and software sales which is offset by $0.5 million because of a write-down of aged receivables tied to discontinued ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

The amezalpat arm was favored regarding hazard ratio for key survival end points. The median progression-free survival in the ...